Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Peringkat dalam Saham #477
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Harga Saham
$19.63
Kapitalisasi Pasar
$47.10B
Perubahan (1 hari)
1.80%
Perubahan (1 tahun)
-7.33%
Negara
IN
Perdagangan Sun Pharmaceutical Industries Limited (SUNPHARMA)

Kategori

Laba untuk Sun Pharmaceutical Industries Limited (SUNPHARMA)
Laba pada Dec 2025 TTM: $1.64B
Menurut laporan keuangan terbaru dari Sun Pharmaceutical Industries Limited, laba saat ini perusahaan adalah $1.64B. Pada tahun 2024, perusahaan memperoleh laba sebesar $1.33B, peningkatan dibandingkan laba tahun 2023 sebesar $1.14B. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Sun Pharmaceutical Industries Limited dari 2004 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $1.64B 2.22%
2025 $1.61B 21.21%
2024 $1.33B 16.34%
2023 $1.14B 93.65%
2022 $588.17M 54.49%
2021 $380.72M -42.58%
2020 $663.01M 20.88%
2019 $548.49M 3.41%
2018 $530.42M -62.03%
2017 $1.40B 40.80%
2016 $992.01M -3.13%
2015 $1.02B 33.99%
2014 $764.30M -3.90%
2013 $795.33M 20.15%
2012 $661.93M 44.90%
2011 $456.82M 45.01%
2010 $315.02M -17.95%
2009 $383.94M -3.94%
2008 $399.69M 107.87%
2007 $192.27M 43.47%
2006 $134.02M 39.03%
2005 $96.39M 9.76%
2004 $87.82M 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$651.61M -60.31%
FR
$3.88B 136.40%
DE
$1.32B -19.32%
JP
$3.36B 104.66%
US
$4.84B 194.62%
GB